Arm Holdings plc vs 22nd Century Group Inc — how do they compare? Arm Holdings plc trades at $271.86 (market cap $287.22B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Arm Holdings plc is far larger — about 188960.5× 22nd Century Group Inc's market cap, and Arm Holdings plc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| ARM | XXII | |
|---|---|---|
Market Cap | $287.22B | $1.52M |
Sector | Technology | Technology |
52-Week High | $439.46 | $801.00 |
52-Week Low | $104.55 | $3.72 |
Enterprise Value | $283.79B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
ARM stock trades at $271.87, up 1.5% in the last 24 hours, with a bullish technical signal and strong quarterly earnings beats. The company reported robust revenue growth, reaching $4.01 billion in 2025, with a net income margin of 20.25%. Recent news highlights AI-driven optimism, though valuation metrics like a P/E of 274.42 indicate premium pricing.
Outlook is positive with analyst consensus favoring a buy rating (70.37%) and a $329.80 price target, but risks include high valuation sensitivity and competitive pressures in the smartphone market. Earnings growth from AI and data center demand presents opportunity, yet investors must weigh stretched multiples against execution risks.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
Latest headlines on both assets
Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.
Read more on ARM →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →